Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 201 participants.
Also called NCT04491136
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT04491136
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Terminated
Technical summary
Registry record NCT04491136. Allocation not applicable; no masking; primary purpose treatment. Start 2020-11-11 (actual); primary completion 2023-06-08 (actual). Results posted on 2024-10-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
- Acronym
- RHYTHM
- Condition
- Heart Failure
- Intervention (Drug)
- ACEI/ARB
- Intervention (Drug)
- ARNI
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct04491136- Content hash
ecb8c95fcbc6aa15ccd5b3fafe906e80a41122cc50f569c0c16e3118e804c43d